Hirokuni Ikeda

The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells

Hirokuni Ikeda, Naruto Taira, Fumikata Hara et al. · Breast Cancer Research · 2010 · 89 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Evaluation of Breast Lymphatic Pathways with Indocyanine Green Fluorescence Imaging in Patients with Breast Cancer

Yutaka Ogasawara, Hirokuni Ikeda, Mina Takahashi et al. · World Journal of Surgery · 2008 · 87 citations

Medicine, Oncology, Radiology +15

Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer

Takeo Fujita, Hirokuni Ikeda, Naruto Taira et al. · BMC Cancer · 2009 · 70 citations · Full text

Medicine, Molecular Biology, Oncology +14

Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer

Hiroki Sato, Hiromasa Yamamoto, Masakiyo Sakaguchi et al. · Cancer Science · 2018 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5‐fluorouracil) has a synergistic effect in estrogen receptor‐positive breast cancer

Hirokuni Ikeda, Naruto Taira, Tomohiro Nogami et al. · Cancer Science · 2011 · 44 citations · Full text

Medicine, Oncology, Pharmacology +17